SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0000902664-07-000990
Filing Date
2007-02-15
Accepted
2007-02-15 15:21:35
Documents
1

Document Format Files

Seq Description Document Type Size
1 CELL THERAPEUTICS, INC. sc13ga.txt SC 13G/A 21293
  Complete submission text file 0000902664-07-000990.txt   23280
Mailing Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119
Business Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119 2062707100
CELL THERAPEUTICS INC (Subject) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: WA | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-48459 | Film No.: 07627080
SIC: 2834 Pharmaceutical Preparations

Mailing Address 65 EAST 55TH STREET, 35TH FLOOR NEW YORK NY 10022
Business Address 65 EAST 55TH STREET, 35TH FLOOR NEW YORK NY 10022 212 546-7664
TENOR CAPITAL MANAGEMENT Co., L.P. (Filed by) CIK: 0001346554 (see all company filings)

IRS No.: 841641518 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A